Skip to content

Prevention of Remifentanil-induced Postoperative Hyperalgesia With Intravenous Ibuprofen

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02243254
Enrollment
120
Registered
2014-09-17
Start date
2014-07-31
Completion date
Unknown
Last updated
2015-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperalgesia, Ibuprofen, Pain, Postoperative, Remifentanil

Brief summary

Postoperative hyperalgesia has been reported after intraoperative administration of small or high-dose remifentanil. Cyclooxygenase inhibitor exhibit preventive effects on the development of opioid-induced hyperalgesia. The aim of this study is to evaluate the preventive effect of intravenous ibuprofen (Caldolor®) on remifentanil-induced hyperalgesia

Interventions

high dose remifentanil

DRUGIbuprofen

intravenous ibuprofen

low dose remifentanil

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients scheduled for elective pancreaticoduodenectomy

Exclusion criteria

* Patients with chronic pain * Patients with psychiatric disease * Patients with nonsteroidal antiinflammatory drugs allergy * Patients with renail dysfunction * History of drug addiction * Pregnant patient * Inability to use a PCA device

Design outcomes

Primary

MeasureTime frameDescription
cumulative morphine consumptionpostoperative 48 hourscumulative patient-controlled analgesia (PCA) morphine consumption

Secondary

MeasureTime frameDescription
Pain scorepostoperative 1, 3, 6,12, 24, 48 hours Pain scorevisual analogue scale

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026